The term "KIN14K" does not align with established antibody nomenclature or kinase-related antibody targets in the literature. It may represent:
A typographical error: Possible confusion with "KIN001," a combination therapy (pamapimod + pioglitazone) investigated in a phase 2 COVID-19 trial .
A novel compound: If "KIN14K" refers to an emerging antibody, no peer-reviewed data or commercial listings exist in the provided sources.
While "KIN14K Antibody" is not documented, several antibodies targeting kinases or potassium channels are described in the search results:
No matches for "KIN14K Antibody": The search results focus on antibodies targeting potassium channels (Kir2.1, Kir4.1), KIT, or keratins, but none mention "KIN14K."
Potential kinase misattribution: If "KIN14K" refers to a kinase inhibitor, no antibody-based therapies are described in the provided data.
Verify nomenclature: Confirm the correct name of the antibody or target protein.
Explore kinase-related antibodies: Review antibodies targeting kinases (e.g., TBK1/NAK; source ) or potassium channels (e.g., Kir2.1, Kir4.1).
Consult updated databases: Use platforms like PubMed, ClinicalTrials.gov, or antibody vendor catalogs (e.g., Alomone, R&D Systems) for real-time data.
KIN14K (also known as kinesin-4) is a motor protein belonging to the kinesin superfamily found in Oryza sativa Japonica Group (Japanese rice). It functions as part of the cellular transport machinery, playing important roles in intracellular trafficking, cell division, and cytoskeletal organization. The gene is identified by Entrez Gene ID 4339353 and has synonyms including OsJ_19246 . Studying KIN14K provides insights into fundamental cellular processes in plants, particularly related to microtubule-based transport systems and cellular architecture.
While specific commercial antibodies for KIN14K were not detailed in the search results, researchers typically have access to both polyclonal and monoclonal antibodies for kinesin proteins. Polyclonal antibodies offer broader epitope recognition, while monoclonal antibodies provide higher specificity for particular epitopes. For novel proteins like KIN14K, custom antibody development may be necessary, following similar approaches to those used for other kinesin family members or techniques demonstrated in studies like the C11C1 monoclonal antibody development for high-molecular weight kininogen .
Validation of KIN14K antibodies should follow a multi-step process:
Western blot analysis to confirm specificity for the target protein (expected molecular weight of KIN14K)
Immunoprecipitation to verify antibody-antigen binding
Immunohistochemistry or immunofluorescence to confirm appropriate cellular localization
Blocking peptide controls to demonstrate specificity
Testing in knockout/knockdown systems where available
Cross-reactivity testing against related kinesin family members
Similar to validation approaches used for antibodies like C11C1, researchers should ensure the antibody binds to the intended target without non-specific binding .
When performing immunohistochemistry with KIN14K antibodies in plant tissues, researchers should follow this optimized protocol:
Fix plant tissue samples in 4% paraformaldehyde for 24 hours
Perform paraffin embedding and sectioning (5-8 μm thickness)
Deparaffinize sections and perform antigen retrieval using citrate buffer (pH 6.0)
Block with 5% normal serum in PBS with 0.3% Triton X-100
Incubate with primary KIN14K antibody (1:100-1:500 dilution range, optimized per antibody)
Apply secondary antibody conjugated to biotin or fluorophore
For colorimetric detection, use avidin-biotin immunoperoxidase complex similar to methods described for other antibody studies
Counterstain, dehydrate, and mount sections
Include positive controls (tissues known to express KIN14K) and negative controls (primary antibody omitted)
The protocol should be optimized based on specific antibody characteristics and plant tissue type.
For optimal Western blot detection of KIN14K:
Extract total protein from plant tissues using a buffer containing protease inhibitors
Separate proteins on 8-10% SDS-PAGE gels (kinesins are typically large proteins)
Transfer to PVDF membrane (preferable for higher molecular weight proteins)
Block with 5% non-fat dry milk in TBST
Incubate with KIN14K primary antibody (1:1000 suggested starting dilution)
Use HRP-conjugated secondary antibody and enhanced chemiluminescence detection
Expected band size for KIN14K should correspond to predicted molecular weight derived from protein sequence data (XP_015639474.1, XP_015639475.1)
Include positive and negative controls
For challenging detections, consider using gradient gels and optimizing transfer conditions for high molecular weight proteins.
To maintain optimal KIN14K antibody activity:
Store concentrated antibody stocks at -20°C to -80°C in small aliquots to avoid freeze-thaw cycles
Working dilutions can be stored at 4°C with preservatives (0.02% sodium azide) for 1-2 weeks
Monitor antibody performance regularly using positive controls
Avoid exposure to light for fluorophore-conjugated antibodies
Follow manufacturer's specific storage recommendations based on antibody formulation
Record lot numbers and validation data to track performance over time
Proper storage is critical for maintaining consistent results across experiments, particularly for quantitative analyses.
KIN14K antibodies can be valuable tools for studying protein-protein interactions through:
Co-immunoprecipitation (Co-IP):
Lyse plant cells under non-denaturing conditions
Incubate lysates with KIN14K antibody
Capture complexes with Protein A/G beads
Analyze precipitated proteins by mass spectrometry or Western blotting
Proximity Ligation Assay (PLA):
Use KIN14K antibody in combination with antibodies against suspected interaction partners
Detect protein proximity (<40 nm) through rolling circle amplification
Quantify interaction signals microscopically
Chromatin Immunoprecipitation (ChIP) (if relevant):
If KIN14K has nuclear functions, ChIP can identify DNA binding regions
Follow standard ChIP protocols with validated KIN14K antibodies
These approaches can reveal novel interactions and functional relationships between KIN14K and other cellular components in kinesin-mediated transport processes.
When studying KIN14K among related kinesin family members:
Epitope selection:
Pre-adsorption controls:
Pre-incubate antibody with related kinesin proteins
Compare staining patterns before and after pre-adsorption
Knockout/knockdown validation:
Test antibody specificity in tissues with reduced KIN14K expression
Confirm signal reduction proportional to expression level
Multiple antibody approach:
Use antibodies targeting different KIN14K epitopes
Confirm consistent localization/interaction patterns
Bioinformatic analysis:
Perform comprehensive sequence alignment of rice kinesin family
Identify unique sequence regions suitable for specific antibody generation
These strategies help ensure experimental findings are genuinely KIN14K-specific rather than reflecting related kinesin activities.
Combining super-resolution microscopy with KIN14K immunolabeling:
Sample preparation:
Fix cells with methods optimized for structural preservation
Use smaller probes (Fab fragments, nanobodies) for better resolution
Consider dual-color labeling with microtubule markers
Techniques selection:
STED microscopy: Provides 30-80 nm resolution for co-localization studies
STORM/PALM: Achieve 10-20 nm resolution for detailed protein distribution
Expansion microscopy: Physical expansion of samples for conventional microscopes
Quantitative analysis:
Track individual KIN14K-labeled structures
Measure co-localization with cargo markers
Analyze directional movement in live cell imaging
Quantify cluster sizes and distributions
Controls:
Include cytoskeletal disruption controls
Compare wild-type vs. mutant kinesin distributions
Use both N- and C-terminal labeling approaches when possible
This approach can reveal KIN14K's precise localization relative to cellular structures and potential cargo, providing insights into its transport functions in plant cells.
To reduce non-specific background in KIN14K immunostaining:
Optimize blocking:
Test different blocking agents (BSA, normal serum, casein, commercial blockers)
Increase blocking time (2-16 hours) at 4°C
Include 0.1-0.3% Triton X-100 or Tween-20 in blocking solution
Improve antibody conditions:
Titrate antibody concentration to optimal signal-to-noise ratio
Increase washing steps (number and duration)
Consider overnight incubation at 4°C instead of shorter incubations
Tissue-specific optimizations:
For highly autofluorescent plant tissues, use Sudan Black B (0.1-0.3%)
Consider spectral unmixing during image acquisition
Use specific plant tissue clearing protocols before immunostaining
Antibody purification:
Consider pre-adsorption against plant tissue lysates
Use affinity-purified antibodies when available
These approaches parallel techniques used in antibody studies like those for C11C1, where specificity must be carefully controlled .
Essential controls for KIN14K antibody research publications:
Antibody validation controls:
Western blot showing single band of expected molecular weight
Peptide competition/blocking controls
Knockout/knockdown validation where available
Immunoprecipitation followed by mass spectrometry confirmation
Experimental controls:
No primary antibody control
Isotype-matched control antibody (for monoclonals)
Pre-immune serum control (for polyclonals)
Positive control tissue known to express KIN14K
Negative control tissue with minimal KIN14K expression
Quantification controls:
Blinded analysis of images/results
Technical and biological replicates (minimum n=3)
Statistical analysis appropriate to data distribution
Standardized exposure/acquisition parameters
Reporting requirements:
Complete antibody information (source, catalog number, RRID, lot)
Detailed methods including dilutions, incubation times, and temperatures
Raw data availability statement
Similar standards should be applied as demonstrated in immunohistochemistry studies using antibodies like C11C1, where rigorous controls were employed .
For quantitative analysis of KIN14K expression across plant tissues:
Sample preparation standardization:
Process all tissues simultaneously using identical protocols
Include internal calibration standards on each slide/batch
Use consistent fixation times and antibody concentrations
Image acquisition parameters:
Maintain identical exposure settings, gain, and offset values
Capture images below saturation
Use identical objective and zoom settings
Include multiple random fields per sample (n≥5)
Quantification approaches:
Measure integrated density of KIN14K signal
Normalize to tissue area or cell number
Consider ratio to housekeeping protein control
Use automated thresholding algorithms for consistency
Statistical analysis:
Compare multiple tissues using appropriate statistical tests
Report mean, standard deviation, and sample size
Consider hierarchical analysis for nested data
Data presentation:
Present results in standardized tables with tissue types and expression levels
Include representative images alongside quantification
This approach allows for robust comparison of KIN14K expression patterns that can be correlated with tissue-specific functions.
When correlating KIN14K protein levels with gene expression:
Experimental design:
Collect matched samples for protein and RNA analysis
Sample across developmental stages or treatments
Include multiple biological replicates
Methods comparison:
Quantify KIN14K protein by Western blot densitometry or ELISA
Measure mRNA expression by qRT-PCR or RNA-seq
Normalize protein data to loading controls (e.g., actin)
Normalize mRNA data to reference genes
Correlation analysis:
Calculate Pearson or Spearman correlation coefficients
Perform time-lag analysis for protein translation delays
Consider non-linear relationships
Data integration:
Create integrated visualization of protein and mRNA levels
Analyze discrepancies for potential post-transcriptional regulation
Consider protein half-life and stability factors
This approach can reveal regulatory mechanisms controlling KIN14K expression and potential post-transcriptional regulation affecting protein abundance relative to mRNA levels.
To distinguish between KIN14K isoforms:
| Technique | Application | Resolution | Considerations |
|---|---|---|---|
| Isoform-specific antibodies | Western blot, IHC, IP | High specificity for targeted epitopes | Requires unique epitope sequences between isoforms |
| RT-PCR with isoform-specific primers | mRNA detection | Can distinguish splice variants | Does not confirm protein expression |
| 2D gel electrophoresis | Protein separation by pI and MW | Can separate similar proteins with post-translational modifications | Labor-intensive, requires optimization |
| Mass spectrometry | Peptide identification | High resolution, can identify unique peptides | Requires sophisticated equipment and analysis |
| RNA-seq | Transcript identification | Comprehensive view of all expressed isoforms | Informatics-intensive, does not confirm protein |
Based on the search results, KIN14K has multiple isoforms including X1 and X2 variants (XP_015639474.1, XP_015639475.1) . Isoform-specific detection requires careful design of antibodies or primers targeting unique regions in each variant. Mass spectrometry-based proteomics offers the most definitive approach for distinguishing protein isoforms by identifying unique peptide sequences.
For studying KIN14K in plant stress responses:
Stress treatment experimental design:
Apply standardized stress conditions (drought, salt, temperature, pathogens)
Sample at multiple time points (early, middle, late responses)
Include appropriate non-stressed controls
Analytical approaches:
Immunoblotting to quantify total KIN14K protein changes
Immunofluorescence to examine subcellular redistribution
Co-IP to identify stress-specific interaction partners
Fractionation studies to assess cytoskeletal association changes
Functional correlations:
Combine with cytoskeletal visualization
Track organelle movement under stress
Correlate KIN14K changes with physiological responses
Compare wild-type vs. stress-resistant varieties
System-level integration:
Relate KIN14K changes to other molecular stress responses
Consider post-translational modifications under stress
Examine transcriptional vs. translational regulation
This approach can reveal how KIN14K contributes to cellular adaptations under stress conditions, potentially illuminating mechanisms of stress tolerance in crop plants.
For successful KIN14K immunoprecipitation:
Lysis conditions optimization:
Test different buffers (RIPA, NP-40, digitonin-based)
Include protease and phosphatase inhibitors
Optimize salt concentration to maintain interactions
Consider crosslinking for transient interactions
Antibody selection and validation:
Verify IP efficiency with Western blot
Compare different antibody clones if available
Consider epitope tag approaches if endogenous IP is challenging
Test antibody orientation (direct coupling vs. protein A/G capture)
Controls design:
IgG control matching antibody species/isotype
Input sample preservation
Unrelated protein IP as specificity control
Reciprocal IP when possible
Downstream analysis options:
Mass spectrometry for unbiased interaction discovery
Targeted Western blot for suspected partners
Activity assays for functional verification
Structural studies of purified complexes
Careful optimization of these parameters will enhance the specificity and yield of KIN14K interaction studies, potentially revealing novel components of motor protein complexes in plants.